Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stela Novak
Observed names:
Novak Stela,
Novak, Stela
Institution:
Oncology Institute of Vojvodina
Observed institution:
Oncology Institute of Vojvodina
ORCID:
0009-0005-9468-6537
Observed ORCID:
0009-0005-9468-6537
OpenAlex ID:
A5125249508
Microbial allies: Gut microbiome and immunotherapy synergies in colorectal cancer
2026
·
Teodora Urosevic
, Marko Marjanovic
, et al.
·
Archive of oncology
PDF
Emerging therapeutic targets in breast cancer: From molecular mechanisms to future perspectives
2026
·
Stela Novak
, Ivana Kolarov-Bjelobrk
, et al.
·
Archive of oncology
Third and Later Line Therapy in Metastatic Colorectal Cancer – Current Landscape and Future Perspectives
2025
·
Marjanovic Marko
, Biljana Kukic
, et al.
·
Journal of Medical and Radiation Oncology
PDF
Second line treatment of clear cell renal cell carcinoma after progression on a tyrosine kinase inhibitor
2025
·
Popovic, Maja
, Maletin, Nemanja
, et al.
·
Libri Oncologici Croatian Journal of Oncology
Immunotherapy maintenance versus immunotherapy after progression on platinum-based chemotherapy in the treatment of locally advanced or metastatic urothelial cancer
2025
·
Popovic, Lazar
, Popovic, Maja
, et al.
·
Libri Oncologici Croatian Journal of Oncology
Comparation between treatment outcomes among patients with diffuse-large B-cell lymphoma treated between 2003-2010 and 2017-2021 treated with rituximab-based immunochemotherapy
2025
·
Đurić, Stefan
, Popovic, Maja
, et al.
·
Libri Oncologici Croatian Journal of Oncology
First experience with antibody-drug conjugates trastuzumab deruxtecan and sacituzumab-govitecan in heavily pretreated patients with metastatic breast cancer
2025
·
Popovic, Lazar
, Popovic, Maja
, et al.
·
Libri Oncologici Croatian Journal of Oncology
Show more works
View as search
Works count:
7
Citation count:
H-index:
I10-index:
Year
Topic
Type